AZB, White & Case, CAM, Sullivan Cromwell act on Organon’s acquisition by Sun Pharma USA

Sun Pharma and Organon have entered into a definitive agreement under which Sun Pharma will acquire all outstanding shares of Organon for USD 14.00 per share in an all‑cash transaction with an enterprise valuation of USD 11.75 billion.